In Brief: Piroxicam-containing products

Piroxicam-containing products: FDA will seek the advice of the Arthritis Advisory Committee in a future meeting to determine whether the agency should remove drug products containing the non-steroidal anti-inflammatory drug from the market, an April 12 letter from Center for Drug Evaluation & Research Director Janet Woodcock, MD, states. The letter is a tentative response to a Public Citizen Health Research Group citizen petition requesting the removal of piroxicam-containing drug products because of gastrointestinal problems associated with their use...